A new study in the Journal of the American Medical Association shows the potential to diagnose genetic disorders in a developing fetus non-invasively, with a test of the mother's blood. March of Dimes ...
Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw ...
Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and precision medicine, today announced it will expand ...
During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or has certain genetic disorders or anomalies. This information can help ...
A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...
To earn CME related to this news article, click here. January 27, 2009 — Recommendations for clinical practice to screen for and diagnose fetal chromosomal abnormalities, which is considered an ...
When a genomic-based, noninvasive prenatal test that uses cell-free fetal DNA in maternal plasma to rule out common aneuploidies, such as Down syndrome, is used in conjunction with current prenatal ...
Claire Marie Porter is a Pennsylvania-based health and science journalist whose work has been published in Scientific American, The Washington Post, NextCity, WIRED, and Elle, among other publications ...
NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback